Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel and Carboplatin , have enhanced inhibition on non-small-cell lung cancer.
Purity:
>98.0%
CAS Number:
[648904-28-3]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted